NCT02531269View on ClinicalTrials.gov

Effectiveness Of Daclatasvir-Based Regimens In Patients With Chronic Hepatitis C Infection In Europe: Experience From Named Patient Program And From Early Post-Marketing Authorization Period

CompletedOBSERVATIONAL
Enrollment

249

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

February 29, 2016

Study Completion Date

February 29, 2016

Conditions
Hepatitis C
Trial Locations (1)

Unknown

Local Institution, Basel

Sponsors
All Listed Sponsors
collaborator

Basel Institute of Clinical Epidemiology (BICE)

OTHER

lead

Bristol-Myers Squibb

INDUSTRY

NCT02531269 - Effectiveness Of Daclatasvir-Based Regimens In Patients With Chronic Hepatitis C Infection In Europe: Experience From Named Patient Program And From Early Post-Marketing Authorization Period | Biotech Hunter | Biotech Hunter